Medigen Vaccine Biologics Corporation (6547.TWO)
TWD 43.55
(-9.93%)
TWD 43.55
(-9.93%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.44 Billion TWD | 8.41% |
| 2022 | 1.32 Billion TWD | -1.31% |
| 2021 | 1.34 Billion TWD | 73.85% |
| 2020 | 771.51 Million TWD | 27.52% |
| 2019 | 605.03 Million TWD | 29.74% |
| 2018 | 466.33 Million TWD | 38.77% |
| 2017 | 336.03 Million TWD | 53.04% |
| 2016 | 219.58 Million TWD | 19.84% |
| 2015 | 183.23 Million TWD | 69.11% |
| 2014 | 108.35 Million TWD | 41.25% |
| 2013 | 76.7 Million TWD | 248.59% |
| 2012 | 22 Million TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 129.01 Million TWD | -1.58% |
| 2024 Q1 | 131.09 Million TWD | -80.22% |
| 2024 Q3 | 130.61 Million TWD | 7.94% |
| 2023 Q4 | 662.67 Million TWD | 234.16% |
| 2023 Q1 | 224.64 Million TWD | -18.38% |
| 2023 Q3 | 198.31 Million TWD | -44.35% |
| 2023 Q2 | 356.38 Million TWD | 58.65% |
| 2023 FY | 1.43 Billion TWD | 8.41% |
| 2022 Q4 | 275.21 Million TWD | -26.37% |
| 2022 Q2 | 313.09 Million TWD | -13.41% |
| 2022 Q1 | 361.57 Million TWD | -5.26% |
| 2022 FY | 1.32 Billion TWD | -1.31% |
| 2022 Q3 | 373.78 Million TWD | 19.38% |
| 2021 Q2 | 455.21 Million TWD | 60.37% |
| 2021 Q4 | 381.66 Million TWD | 73.03% |
| 2021 Q1 | 283.84 Million TWD | 7.43% |
| 2021 FY | 1.34 Billion TWD | 73.85% |
| 2021 Q3 | 220.57 Million TWD | -51.54% |
| 2020 Q3 | 206.08 Million TWD | 18.79% |
| 2020 FY | 771.51 Million TWD | 27.52% |
| 2020 Q2 | 173.48 Million TWD | 35.83% |
| 2020 Q1 | 127.72 Million TWD | -31.69% |
| 2020 Q4 | 264.21 Million TWD | 28.2% |
| 2019 Q3 | 121.89 Million TWD | -23.5% |
| 2019 FY | 605.03 Million TWD | 29.74% |
| 2019 Q4 | 186.98 Million TWD | 53.4% |
| 2019 Q2 | 159.35 Million TWD | 16.49% |
| 2019 Q1 | 136.79 Million TWD | -15.19% |
| 2018 Q4 | 161.29 Million TWD | 78.18% |
| 2018 FY | 466.33 Million TWD | 38.77% |
| 2018 Q2 | 128.13 Million TWD | 48.34% |
| 2018 Q1 | 86.37 Million TWD | -22.21% |
| 2018 Q3 | 90.52 Million TWD | -29.35% |
| 2017 FY | 336.03 Million TWD | 53.04% |
| 2017 Q4 | 111.03 Million TWD | 44.02% |
| 2017 Q2 | 80.21 Million TWD | 18.51% |
| 2017 Q3 | 77.09 Million TWD | -3.89% |
| 2017 Q1 | 67.68 Million TWD | -23.83% |
| 2016 Q4 | 88.86 Million TWD | 113.49% |
| 2016 Q3 | 41.62 Million TWD | -4.16% |
| 2016 Q1 | 43.43 Million TWD | 1.7% |
| 2016 Q2 | 43.43 Million TWD | 0.0% |
| 2016 FY | 219.58 Million TWD | 19.84% |
| 2015 Q3 | 42.7 Million TWD | -11.06% |
| 2015 Q1 | 48.01 Million TWD | 76.04% |
| 2015 Q2 | 48.01 Million TWD | 0.0% |
| 2015 FY | 183.23 Million TWD | 69.11% |
| 2015 Q4 | 42.7 Million TWD | 0.0% |
| 2014 FY | 108.35 Million TWD | 41.25% |
| 2014 Q4 | 27.27 Million TWD | 0.0% |
| 2014 Q3 | 27.27 Million TWD | 5.9% |
| 2014 Q2 | 25.75 Million TWD | 0.0% |
| 2014 Q1 | 25.75 Million TWD | 0.0% |
| 2013 FY | 76.7 Million TWD | 248.59% |
| 2012 FY | 22 Million TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -438821.277% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | -1031.081% |
| Level Biotechnology Inc. | 151.99 Million TWD | -850.077% |
| Sagittarius Life Science Corp | 135.85 Million TWD | -962.951% |
| NeoCore Technology Co., Ltd. | 75.85 Million TWD | -1803.599% |
| TaiMed Biologics Inc. | 225.23 Million TWD | -541.137% |
| GlycoNex Incorporation | 995 Thousand TWD | -145030.754% |
| VBI | 32.55 Million TWD | -4335.727% |
| GeneReach Biotechnology Corp. | 256.86 Million TWD | -462.174% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | -643.643% |
| SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -3037.672% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | -1104.279% |
| Visgeneer Inc. | 67.48 Million TWD | -2039.905% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 484.884% |
| Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | -183.095% |
| G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | -2159.755% |
| Neith Corporation | 66.87 Million TWD | -2059.393% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -4819.77% |
| Enimmune corporation | 220.1 Million TWD | -556.083% |
| TaiRx, Inc. | 217.13 Million TWD | -565.051% |
| CHO Pharma, Inc. | 268.99 Million TWD | -436.826% |
| EirGenix Inc. | 236.74 Million TWD | -509.971% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | -1283.84% |
| Sunny Pharmtech Inc. | 357.62 Million TWD | -303.793% |
| Lin BioScience, Inc. | 1.09 Billion TWD | -31.657% |
| BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | -442.552% |
| Feng Chi Biotech Corp. | 49.47 Million TWD | -2818.985% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -133238.042% |
| Lukas Biomedical Inc. | 177.45 Million TWD | -713.779% |
| RBC Bioscience Corporation | 58.35 Million TWD | -2374.554% |
| BiOptic Inc. | 108.69 Million TWD | -1228.572% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -1604401.111% |
| Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | -1982.265% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -55121.836% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | -124.26% |
| Advagene Biopharma Co., Ltd. | 93.33 Million TWD | -1447.153% |
| NaviFUS Corp. | 11.82 Million TWD | -12109.783% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | -657.122% |
| Sinew Pharma Inc. | 186.25 Million TWD | -675.317% |
| Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | -1850.814% |
| Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | -555.201% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -3381.235% |
| AP Biosciences Inc | 32.25 Million TWD | -4377.261% |
| Medigen Biotechnology Corp. | 1.85 Billion TWD | 21.961% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -27280.565% |
| Pharmosa Biopharm Inc. | 317.32 Million TWD | -355.071% |
| Intech Biopharm Corporation | -163.99 Million TWD | 980.546% |
| Oneness Biotech Co., Ltd. | 1.12 Billion TWD | -27.884% |
| Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -3381.151% |
| TWi Biotechnology, Inc. | 169.55 Million TWD | -751.666% |
| Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | -882.201% |
| TCI GENE Inc. | 174.61 Million TWD | -726.982% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -8022405.556% |
| Senhwa Biosciences, Inc. | 300.93 Million TWD | -379.85% |
| Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | -396.311% |
| NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | -1620.235% |
| PharmaEngine, Inc. | 441.78 Million TWD | -226.864% |
| Savior Lifetec Corporation | 223.36 Million TWD | -546.487% |
| TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | -458.025% |
| OBI Pharma, Inc. | 2.01 Billion TWD | 28.381% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | -939.858% |
| Acepodia, Inc. | 452.56 Million TWD | -219.08% |
| Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | -166.954% |